Morgan Conn's most recent trade in Century Therapeutics Inc was a trade of 19,500 Common Stock done . Disclosure was reported to the exchange on March 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Morgan Conn | Chief Finanical Officer | 11 Mar 2025 | 19,500 | 79,648 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Morgan Conn | Chief Finanical Officer | 11 Mar 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Morgan Conn | Chief Finanical Officer | 14 Oct 2024 | 360,890 | 360,890 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Morgan Conn | Chief Finanical Officer | 14 Oct 2024 | 60,148 | 60,148 | - | 0 | Common Stock |